PAD-PF2

PAD-PF2 : allosteric inhibitor of PADI1, PADI2, PADI3 and PADI4

Structure

Information

  • PADI1
  • PADI2
  • PADI3
  • PADI4
  • allosteric
  • up to 10 uM

In Vitro Validations

Uniprot ID: Q9ULC6
Target Class: Enzyme
Target SubClass: Deiminase
Potency: IC50
Potency Value: 109 nM
Potency Assay: Glutamate dehydrogenase (GDH) enzyme-coupled assay
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Protein-arginine deiminase type-1, PDI1, PAD1, PAD ...

DOI Reference: 10.1038/s41467-025-59919-4

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay (off target): The target specificity of PAD-PF2 was evaluated by profiling the compound against a diverse panel of receptors, enzymes, kinases, transporters, and ion channels at a dose of 10 µM concentration . PAD-PF2 showed > 80-fold selectivity relative to the PAD4 enzymatic IC50 value. Among the targets tested above, PAD-PF2 was found to be a weak agonist of the κ-opioid receptor (EC50 = 7.55 µM, 177-fold) and weak antagonist of the M1 muscarinic acetylcholine receptor (IC50 = 12.3 µM, 288-fold). Also, weak binding affinity was observed to the choline transporter (Ki = 3.45 µM, 81-fold) and the L-type calcium ion channel (Ki = 11.1 µM, 260-fold).
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

Overall, this probe seems to be clearly investigated and the data in the paper (DOI: 10.1038/s41467-025-59919-4) is in-depth. This probe is definitely useful as a PAD probe, but may be useful in combination with active site PAD probes.

(last updated: 27 May 2025 )